AN IMPROVED FLUORESCENCE ASSAY FOR THE DETERMINATION OF LYMPHOCYTE-MEDIATED CYTOTOXICITY USING FLOW-CYTOMETRY

被引:225
作者
PAPADOPOULOS, NG
DEDOUSSIS, GVZ
SPANAKOS, G
GRITZAPIS, AD
BAXEVANIS, CN
PAPAMICHAIL, M
机构
[1] Immunology Department, Hellenic Anticancer Institute, 11522 Athens
关键词
NATURAL KILLER; LYMPHOKINE-ACTIVATED KILLER; CELL-MEDIATED LYMPHOLYSIS; CYTOTOXICITY; FLUORESCENCE; FLOW CYTOMETRY;
D O I
10.1016/0022-1759(94)90147-3
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The use of the chromium-release assay to determine cytotoxicity of effector against target cells has various limitations mostly due to the inherent properties of the radioactive substance. We have developed an improved flow cytometric method that is able to measure cytotoxicity, based on two fluorescent dyes. Calcein-AM, a non-fluorescent substance which is intracellularly converted to the green fluorescent calcein by esterase activity in viable cells, is initially used to stain target cells. After incubating targets with effecters for 2 h, ethidium homodimer-1, a red DNA stain non-permeable to viable cells, is added. Dead target cells are distinguished by their double (green-red) staining. Data analysis is performed by gating the regions of living target, dead target and living effector cells, based on appropriate controls. Non-specific events are subtracted from the dead target region and the ratio of specific dead target events to total target events is expressed as percent cytotoxicity. The method is used to quantify natural killer (NK) and lymphokine-activated killer (LAK) activities against the human K562 and Daudi cell lines and the murine YAC-1 and L1210 cell lines respectively, as well as cell-mediated lympholysis (CML) exerted by tumor-infiltrating lymphocytes (TIL) against autologous and allogeneic human breast cancer tumor cells. The method is fast, reliable and correlates well with the standard Cr-51-release assay.
引用
收藏
页码:101 / 111
页数:11
相关论文
共 32 条
[1]   PROTHYMOSIN-ALPHA RESTORES DEPRESSED ALLOGENEIC CELL-MEDIATED LYMPHOLYSIS AND NATURAL-KILLER-CELL ACTIVITY IN PATIENTS WITH CANCER [J].
BAXEVANIS, CN ;
RECLOS, GJ ;
PAPAMICHAIL, M .
INTERNATIONAL JOURNAL OF CANCER, 1993, 53 (02) :264-268
[2]   INDUCTION OF LYMPHOKINE-ACTIVATED KILLER ACTIVITY IN MICE BY PROTHYMOSIN-ALPHA [J].
BAXEVANIS, CN ;
GRITZAPIS, AD ;
DEDOUSSIS, GVZ ;
PAPADOPOULOS, NG ;
TSOLAS, O ;
PAPAMICHAIL, M .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1994, 38 (04) :281-286
[3]  
BAXEVANIS CN, 1993, CANCER-AM CANCER SOC, V72, P491, DOI 10.1002/1097-0142(19930715)72:2<491::AID-CNCR2820720227>3.0.CO
[4]  
2-1
[5]  
BAXEVANIS CN, 1994, IN PRESS CANCER
[6]  
BAXEVANIS CN, 1994, IN PRESS CRIT REV ON
[7]  
BAXEVANIS CN, 1994, IN PRESS BR J CANCER
[8]   EUROPIUM-LABELED TARGET-CELLS IN AN ASSAY OF NATURAL-KILLER CELL-ACTIVITY .1. A NOVEL NONRADIOACTIVE METHOD BASED ON TIME-RESOLVED FLUORESCENCE [J].
BLOMBERG, K ;
GRANBERG, C ;
HEMMILA, I ;
LOVGREN, T .
JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 86 (02) :225-229
[9]   THE SINGLE-CELL ASSAY IN CELL-MEDIATED CYTO-TOXICITY [J].
BONAVIDA, B ;
BRADLEY, TP ;
GRIMM, EA .
IMMUNOLOGY TODAY, 1983, 4 (07) :196-200
[10]  
BRUNNER KT, 1968, IMMUNOLOGY, V14, P18